Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogene
about
Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products.Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization.Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts.Methylglyoxal increases cardiomyocyte ischemia-reperfusion injury via glycative inhibition of thioredoxin activity.LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells.The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptorOxidative stress caused by inactivation of glutathione peroxidase and adaptive responses.Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets.A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients.Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study.Glucose-based peritoneal dialysis solution suppresses adiponectin synthesis through oxidative stress in an experimental model of peritoneal dialysisMechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis.Methylglyoxal, diabetes mellitus and diabetic complications.Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.Protective measures against ultrafiltration failure in peritoneal dialysis patientsAssociation of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventionsEffects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels.Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E.Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction.Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling.A High-Throughput Targeted Proteomic Approach for Comprehensive Profiling of Methylglyoxal-Induced Perturbations of the Human KinomeMineralocorticoids upregulate arterial contraction to epidermal growth factor.Methylglyoxal-induced apoptosis is dependent on the suppression of c-FLIPL expression via down-regulation of p65 in endothelial cells.Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal.Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products.Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells.Cardiac overexpression of catalase antagonizes ADH-associated contractile depression and stress signaling after acute ethanol exposure in murine myocytes.
P2860
Q30376144-279897C5-74B9-4DA3-9658-32CF67634E8CQ30812494-73E549FB-40C8-4B6A-91CA-4399AE4F6F2CQ33865328-D3B05DF5-2CAF-4931-925C-EA4F7C44BD09Q34085212-96C470E4-46D0-40B4-8656-0C7DB200F0D2Q34214122-434A8A4D-9CFB-4614-B57B-3E727329EA11Q34490546-8DE049B4-16D9-464B-AA0F-E0FC7D4BB6F9Q35025205-CC8E256E-292B-475C-BB24-21EDEAC51A53Q35129265-7CB3DBE3-6CEE-441E-BECE-119AA3297A6DQ35865399-63A9CB96-15C5-4C81-9804-D81A7E57355CQ35994373-210818E2-6FD1-45B4-8D6F-8C689C0EF9F7Q36386616-DE9C7DC6-E03B-4904-A3DE-865296C3386EQ36475555-F096C1C8-B6D1-4AE7-AF24-459EDD8750A8Q37046408-9D89FCA4-EDB1-4863-8F3F-FE454611CDDFQ37183293-D01BAA0C-8532-47AC-95C1-3511002591E7Q37228204-C0E664B1-2C44-42FD-96A9-CC05EFF235EDQ37970606-8617768E-732D-4D39-922B-3F4261B968ABQ38199486-DC63A067-71CC-48FB-BC02-3B90F6360859Q38961508-93CB2693-13AC-4461-8EE2-E672F613F39DQ39485974-1D225B4A-5285-4821-B9DF-70F42D7EC656Q39690794-EAB88BF4-789B-4B67-B9E7-312C83F9F949Q40100612-1AE6EF39-3F3D-4943-8409-036F28E9B44DQ41976211-94A4C624-0184-4D4F-AC6C-12E8D6098338Q43708488-4B2C4EB3-7479-46C1-9109-66A85984B61AQ43741333-4D5415BC-1E34-4FDB-8B37-64E442DEA656Q44024811-1DC58F35-F54F-4B3D-986C-D866B70AAB07Q44378754-BCD949E0-BCD2-4F43-8E28-E8E9FA63D34AQ46613107-022966C6-E243-4089-853F-732C347448F7Q46658385-FEF5F97B-8D37-407D-8107-82A45A967FEA
P2860
Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogene
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Selective induction of heparin ...... ble implication for atherogene
@ast
Selective induction of heparin ...... ble implication for atherogene
@en
Selective induction of heparin ...... ble implication for atherogene
@nl
type
label
Selective induction of heparin ...... ble implication for atherogene
@ast
Selective induction of heparin ...... ble implication for atherogene
@en
Selective induction of heparin ...... ble implication for atherogene
@nl
prefLabel
Selective induction of heparin ...... ble implication for atherogene
@ast
Selective induction of heparin ...... ble implication for atherogene
@en
Selective induction of heparin ...... ble implication for atherogene
@nl
P2093
P2860
P356
P1476
Selective induction of heparin ...... for atherogenesis in diabetes
@en
P2093
P2860
P304
18453-18459
P356
10.1074/JBC.272.29.18453
P407
P577
1997-07-01T00:00:00Z